Ronald is a graduate of the University of Tilburg in the Netherlands and holds a Master’s degree in Business Economics. He is also a Chartered Accountant. Prior to joining Centrient Pharmaceuticals in April 2019, Ronald spent eight years as the CFO of Wessanen, where he played a key role in the transformation of the company into a pure player, focused on healthy and sustainable food in Europe.

His time with the company followed successful spells at Britax (part of the Carlyle private equity group) in the UK, as well as Unilever.